GlassScriptPhysician profile
Andrew J Bryan
NPI 1134482284
$15,440.31
in general payments reported to CMS, 2019-2025
20 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,695 · 2020: $28.16 · 2021: $2,636 · 2022: $3,307 · 2023: $5,080 · 2024: $1,657 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,597 · Food and Beverage: $2,328 · Consulting Fee: $1,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,596.61 |
| Food and Beverage | $2,327.61 |
| Consulting Fee | $1,850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $7,784.81 | 2021-2024 | |
| Stryker Corporation | $2,771.03 | 2019-2025 | Mako, Triathlon |
| Heraeus Medical, LLC. | $1,525.13 | 2020-2024 | Palacos |
| Zimmer Biomet Holdings, INC. | $1,466.03 | 2019-2024 | Persona, Tapestry |
| Arthrex, INC. | $565.67 | 2022-2023 | |
| Intellijoint Surgical INC. | $500.00 | 2025 | Intellijoint Hip |
| Depuy Synthes Sales INC. | $215.99 | 2024-2025 | Na, Velys, Monovisc |
| Smith+Nephew, INC. | $154.95 | 2019-2025 | Stravix Pl |
| Ethicon US, LLC | $137.36 | 2025 | Dermabond Prineo, Stratafix |
| Encore Medical, LP | $64.28 | 2024 | Djo Surgical |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Davol INC. | $32.59 | 2023 | Arista Ah Flexitip |
| Nalu Medical, INC. | $31.41 | 2024 | Nalu Neurostimulation System |
| Bioventus LLC | $27.58 | 2022-2023 | Durolane |
| Treace Medical Concepts, INC. | $21.67 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $20.76 | 2019 | |
| Heron Therapeutics, INC. | $17.13 | 2023 | Zynrelef |
| Medtronic, INC. | $17.05 | 2023 | Venaseal |
| Orthogenrx INC. | $14.12 | 2019 | |
| Vericel Corporation | $13.75 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.